Find and Pitch Jounalists, Get Your Story Covered

Tags: psilocybin Brain networks Neuroscience Oregon mental health care

	Profile	Recent Articles on Subject
1	Mack DeGeurin Popular Science Tech policy reporter. Hosts 'The Future is Ow' podcast. New York, New York Tech PolicyReporting	This robot is being controlled by a King oyster mushroom - 14 days ago
2	Kristen Monaco MedPage Today	More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 15 days ago FDA Rejects MDMA-Assisted Therapy for PTSD - about 1 month ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 7 months ago Psychedelics for Psych Conditions Made Their Mark in 2023 - 9 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - 10 months ago Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression - 10 months ago
3	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - about 1 month ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - about 1 month ago A tough week for MDMA-assisted psychotherapy - about 1 month ago STAT+: Three MDMA therapy papers retracted over data integrity concerns - about 1 month ago FDA rejects MDMA as a psychedelic treatment for PTSD - about 1 month ago Psychedelic investment continues to ramp up - 7 months ago
4	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Uncertain Path Forward for Psychedelic Medicine - about 1 month ago The FDA Just Rejected a Bid for MDMA to Treat PTSD - about 1 month ago The Case for MDMA’s Approval Is Riddled With Problems - 3 months ago They Had PTSD. A Psychedelic Called Ibogaine Helped Them Get Better - 9 months ago
5	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Listen: Drug pricing drops & psychedelics under fire - about 1 month ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	Listen: Drug pricing drops & psychedelics under fire - about 1 month ago
7	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	Listen: Drug pricing drops & psychedelics under fire - about 1 month ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about FDA rejecting MDMA; a nasal spray for allergic reactions, and more - about 1 month ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Declines to Approve MDMA for PTSD - about 1 month ago Psychedelic Medicine Could Fill Care Gap in Psychiatric Care - 5 months ago Is 2024 the Year for Psychedelic Medicine? - 6 months ago FDA Accepts New Drug Application for MDMA-Assisted Therapy for PTSD - 7 months ago
10	Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York consciousnesseconomicspodcasting	MDMA therapy didn’t get FDA approval. Now what? - about 1 month ago How should we sell psychedelics? - 2 months ago Psychedelics are about to become a casualty of Oregon’s opioid crisis - 6 months ago China’s emerging psychedelic scene looks a lot like Silicon Valley - 7 months ago Why psychedelics produce some of the most meaningful experiences in people’s lives - 10 months ago Robin Carhart-Harris studies psychedelics to understand the mind - 10 months ago Psychedelics can have enormous benefits, but the risks shouldn’t be ignored - 10 months ago

Journalists covering psilocybin